Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer.
about
Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Momelotinib decreased cancer s ...... model of human ovarian cancer.
@en
Momelotinib decreased cancer s ...... model of human ovarian cancer.
@nl
type
label
Momelotinib decreased cancer s ...... model of human ovarian cancer.
@en
Momelotinib decreased cancer s ...... model of human ovarian cancer.
@nl
prefLabel
Momelotinib decreased cancer s ...... model of human ovarian cancer.
@en
Momelotinib decreased cancer s ...... model of human ovarian cancer.
@nl
P2093
P2860
P356
P1433
P1476
Momelotinib decreased cancer s ...... model of human ovarian cancer.
@en
P2093
Christopher Burns
Emily Chan
George Kannourakis
Jock K Findlay
Nuzhat Ahmed
P2860
P304
16599-16618
P356
10.18632/ONCOTARGET.24615
P407
P577
2018-03-30T00:00:00Z